Observations placeholder
Aptivus
Identifier
024018
Type of Spiritual Experience
Background
A description of the experience
Tipranavir, or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) marketed under the trade name Aptivus. It is administered with ritonavir in combination therapy to treat HIV infection.
Most common Aptivus side effects
- Exomphalos - (60 reports)
- Cloacal exstrophy - (55 reports)
- Lipodystrophy acquired - (54 reports)
- Caudal regression syndrome - (53 reports)
- Bladder agenesis - (53 reports)
- Haemorrhage intracranial - (51 reports)
- Meningomyelocele - (51 reports)
- Umbilical cord abnormality - (51 reports)
- Genitalia external ambiguous - (50 reports)
- Blood iron decreased - (48 reports)